← Back to Search

Psychological Resilience Training for Stress Management in Military Personnel (R2OE Trial)

N/A
Recruiting
Led By Alan Peterson, PhD
Research Sponsored by The University of Texas Health Science Center at San Antonio
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adult 18 or older
Male or female soldiers assigned to the 3rd SFAB
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 16 months
Awards & highlights

R2OE Trial Summary

This trial will compare a training program based on Acceptance and Commitment Training (ACT) to regular training for 600 soldiers in the 3rd Security Force Assistance Brigades (SFABs) at Fort Hood, TX. The goal is to see if the ACT-based program enhances resilience (the ability to cope with stress and adversity).

Who is the study for?
This trial is for adult men and women who are part of the 3rd Security Force Assistance Brigades at Fort Hood, Texas. It's focused on soldiers who need to maintain high levels of psychological resilience due to their demanding missions.Check my eligibility
What is being tested?
The study tests a program called Acceptance and Commitment Training (ACT) aimed at enhancing resiliency in military personnel against usual training methods. Participants will be assessed over a period of 16 months, including before and after deployment.See study design
What are the potential side effects?
Since this intervention involves psychological flexibility training rather than medication or medical procedures, traditional physical side effects are not expected. However, participants may experience emotional discomfort during the process.

R2OE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I am a soldier assigned to the 3rd SFAB.

R2OE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 16 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 16 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Connor-Davidson Resilience Scale (CD-RISC)
Secondary outcome measures
Acceptance and Action Questionnaire-II (AAQ-II
Dispositional Recovery and Dysfunction Inventory (DRDI)
General Functioning 12-item subscale (GF12) of the McMaster Family Assessment Device (FAD)
+4 more
Other outcome measures
Deployment Risk and Resilience Inventory-2 (DRRI-2) Deployment Environment Scale
Anxiety Disorders
Implicit Theories of Intelligence Scale (ITIS)
+4 more

R2OE Trial Design

2Treatment groups
Active Control
Group I: Training as usualActive Control1 Intervention
Training as Usual for the 3rd SFAB is the U.S. Army Master Resilience Trainer (MRT). It focuses on teaching resilience skills and is one of the foundational pillars of the Comprehensive Soldier Fitness program. MRT course is intended to impart training resilience skills, designed to introduce other resilience concepts that soldiers will likely encounter through their careers. Key focus of course are (1) resilience, (2) building mental toughness, (3) identifying character strengths, and (5) strengthening relationships. The 3rd SFAB uses a a team training grounded in strengths-based leadership. The Small Team Development Consultant and Brigade Behavioral Health Provider serves as a consultant to units conducting their own resiliency training as usual. No booster sessions will be offered to Training as Usual.
Group II: Training as usual with psychological flexibility trainingActive Control1 Intervention
Training as usual, with psychological flexibility training delivered during a 2-day workshop. Day 1 provides an overview of the training and describes the posture or stance to prepare for response to challenging situations in a psychologically flexible manner. Day 2 provides common coping strategies.

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center at San AntonioLead Sponsor
454 Previous Clinical Trials
90,176 Total Patients Enrolled
Alan Peterson, PhDPrincipal InvestigatorUniversity of Texas Health San Antonio
2 Previous Clinical Trials
312 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current population involved in this experimental research?

"Affirmative. Clinicaltrials.gov records detail that this clinical trial, which was posted on October 4th 2021, is currently accepting applications. 600 participants need to be recruited from one healthcare centre."

Answered by AI

Are there still opportunities for individuals to participate in this research endeavor?

"Affirmative. Per clinicaltrials.gov, this research project is actively searching for participants since it was originally posted on October 4th 2021 and modified lastly on December 10th 2021. Approximately 600 patients from a single medical facility are needed to complete the trial."

Answered by AI
~177 spots leftby Jul 2025